H.R. 6664 · 119th Congress · Armed Forces and National Security
To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.
- IntroducedDec 11, 2025 Done
- CommitteeReferred to Armed Services Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Full text
No CRS summary yet · 484 wordsH.R. 6664 · Introduced in House · Dec 11, 2025
(a) Designation of senior official. Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall designate a senior official, with relevant biotechnology experience, from a position within the Department of Defense that was in effect on the day before the date of the enactment of this Act, to— (1) be the senior official for biotechnology issues; (2) be the head of the Biotechnology Management Office established under subsection (b); and (3) carry out the responsibilities for the office in subsection (c).
(b) Establishment of Biotechnology Management Office. Not later than 120 days after the date of the enactment of this Act, the Secretary of Defense shall, with input from the senior official designated under subsection (a), charter and establish, under the authority, direction, and control of the Deputy Secretary of Defense, a Biotechnology Management Office to foster the development, acquisition, and sustainment of broad-based biotechnology capabilities for the Department.
(c) Responsibilities. The office established under subsection (b) shall be responsible for the following: (1) Maintaining and executing a long-term research, development, acquisition, and sustainment roadmap. (2) Updating policies and guidance within the Department relating to the acquisition, adoption, and transition of biotechnology-based products into Department use. (3) Coordinating with activities across the Department, the Federal Government, industry, academia, and international partners relating to biotechnology. (4) Proposing options for streamlining the regulatory or acquisition process of the Department. (5) Conducting, as may be needed, global competition analyses, net assessment, or forecasting to support decisionmakers on biotechnology advances. (6) Supporting the development of public-private partnerships with academia, industry, and other State and local government partners, including through the development or fostering of regionally focused innovation ecosystems. (7) Identifying biotechnology workforce and training gaps across the workforce of the Department. (8) Such other responsibilities as the Secretary considers appropriate.
(d) Sunset. This section shall terminate on September 30, 2030.
(e) Briefing. Not later than 30 days after the designation of the senior official pursuant to subsection (a), the Secretary shall provide to the congressional defense committees a briefing on the proposed scope of the charter for the office to be established pursuant to subsection (b), as well as implementation plans for preliminary activities the office will pursue during the proceeding one-year period.
Section 215 of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 ( Public Law 117–263 ; 10 U.S.C. 4841 note) is amended— by redesignating subsections (d) through (f) as subsections (e) through (g), respectively; and by inserting after subsection (c) the following new subsection:
(d) Funding. Funds authorized to be appropriated or otherwise made available to the Department of Defense for research, development, test, and evaluation may be used to carry out the activities described in subsection (c), including the design and construction activities described in subsection (c).
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
1 organization · 1 filing · Q4 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
National Multifamily Housing Council Inc
1 of 4 quarters
“…H.R. 6664, 21st Century ROAD to Housing Act, Sec. 503: Rural Housing Service Reform Act and Sec. 901: Homes are for people, not corporations. H. Res. 1299, Providing for the concurrence by the House in the Senate amendment to H.R. 6644, with amendment, all provisions, and in particular Sec 1001: Homes are for people…”
$6.7M lobbying spend in 2026 to date, all issuesQ2 2026 filing
Organizations that named H.R. 6664 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Dec 11, 2025Referred to the House Committee on Armed Services.
- Dec 11, 2025Introduced in House